Lantigen B Bacterial Vaccine - For the Treatment of Catarrh, Chronic Bronchitis, and Bronchial Asthma
Object Details
- Edinburgh Laboratories
- Description
- The indications or uses for this product as provided by the manufacturer are:
- For the treatment of catarrh, chronic bronchitis, bronchial asthma
- Location
- Currently not on view
- Credit Line
- Gift of Richard W. Pollay
- 1944-12-29
- expiration date
- 1945-06-29
- ID Number
- 2008.0018.142
- accession number
- 2008.0018
- catalog number
- 2008.0018.142
- Object Name
- biological
- vaccine, respiratory infections, bacterial
- Object Type
- OTC Preparation
- Physical Description
- pneumococci, 1000 million detoxified antigens per cc. (drug ingredient)
- M. catarrhalis, 1000 million detoxified antigens per cc. (drug ingredient)
- streptococci, 1000 million detoxified antigens per cc. (drug ingredient)
- staphylococci, 500 million detoxified antigens per cc. (drug ingredient)
- Bact.. friedlaenderi, 500 million detoxified antigens per cc. (drug ingredient)
- H. influenzae, 500 million detoxified antigens per cc. (drug ingredient)
- Measurements
- overall: 2 in x 3 1/2 in; x 5.08 cm x 8.89 cm
- overall, box: 3 3/8 in x 2 1/8 in x 1 1/4 in; 8.5725 cm x 5.3975 cm x 3.175 cm
- place made
- Australia: New South Wales, City of Sydney
- See more items in
- Medicine and Science: Medicine
- The Antibody Initiative
- Health & Medicine
- Antibody Initiative: Influenza
- National Museum of American History
- Record ID
- nmah_1348544
- Metadata Usage (text)
- CC0
- GUID (Link to Original Record)
- https://n2t.net/ark:/65665/ng49ca746ac-ba00-704b-e053-15f76fa0b4fa
Related Content
There are restrictions for re-using this image. For more information, visit the Smithsonian's Terms of Use page .
International media Interoperability Framework
IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more.